Markus Susani

Title: Innovations of Markus Susani

Introduction

Markus Susani is a notable inventor based in Salzburg, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides and diagnostic methods for allergies. With a total of 3 patents, his work has advanced the understanding and treatment of allergic reactions.

Latest Patents

Markus Susani's latest patents include groundbreaking inventions related to recombinant DNA molecules. One of his notable patents involves a recombinant DNA molecule that codes for polypeptides displaying the antigenicity of various Phl p I epitope clones. This invention is crucial for diagnosing allergies in vitro. Additionally, he has developed diagnostic methods utilizing these polypeptides in immunoassays for humoral antibodies and cellular reactions. His work also encompasses recombinant expression vectors and host cells transformed with these vectors, which are essential for therapeutic applications.

Career Highlights

Throughout his career, Markus Susani has worked with prominent companies in the biotechnology sector, including Pharmacia & Upjohn and Phadia. His expertise in recombinant DNA technology has positioned him as a key figure in allergy research and diagnostics. His contributions have not only advanced scientific knowledge but have also paved the way for new therapeutic approaches.

Collaborations

Markus has collaborated with esteemed colleagues such as Tanja Ball and Susanne Vrtala. These partnerships have further enriched his research and have led to innovative solutions in the field of allergy diagnostics.

Conclusion

Markus Susani's work exemplifies the impact of innovation in biotechnology. His patents and collaborations have significantly contributed to advancements in allergy diagnosis and treatment. His ongoing research continues to inspire future developments in this vital area of health science.